257 related articles for article (PubMed ID: 21244554)
21. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
22. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
23. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
Bailey KS; Dewey CW; Boothe DM; Barone G; Kortz GD
J Am Vet Med Assoc; 2008 Mar; 232(6):867-72. PubMed ID: 18341442
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
25. Preliminary efficacy of levetiracetam in monotherapy.
Ben-Menachem E
Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
[TBL] [Abstract][Full Text] [Related]
26. New onset paediatric epilepsy in 1-5 years age group children--approach to management in a tertiary care centre with newer anti-epileptic levetiracetam.
Barik KL; Paul UK; Bhattacharyya AK; Adhikary A; Agarwal G; Rana KS
J Indian Med Assoc; 2014 Feb; 112(2):100-2. PubMed ID: 25935964
[TBL] [Abstract][Full Text] [Related]
27. Intravenous levetiracetam in the management of acute seizures in children.
Reiter PD; Huff AD; Knupp KG; Valuck RJ
Pediatr Neurol; 2010 Aug; 43(2):117-21. PubMed ID: 20610122
[TBL] [Abstract][Full Text] [Related]
28. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
[TBL] [Abstract][Full Text] [Related]
29. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
30. Levetiracetam: preliminary efficacy in generalized seizures.
Kasteleijn-Nolst Trenité DG; Hirsch E
Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
[TBL] [Abstract][Full Text] [Related]
31. Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series.
Bilo L; Meo R; de Leva MF; De Simone R; Di Nocera P; Pisani F; Striano S
Clin Neuropharmacol; 2008; 31(4):221-5. PubMed ID: 18670245
[TBL] [Abstract][Full Text] [Related]
32. Levetiracetam: a new therapeutic option for refractory epilepsy.
Pinto A; Sander JW
Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
[TBL] [Abstract][Full Text] [Related]
33. Levetiracetam as add-on therapy in generalised epilepsies.
Kumar SP; Smith PE
Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
[TBL] [Abstract][Full Text] [Related]
34. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel C; Holthausen H; Kluger G
Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
[TBL] [Abstract][Full Text] [Related]
35. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
Szucs A; Clemens Z; Jakus R; Rásonyi G; Fabó D; Holló A; Barcs G; Kelemen A; Janszky J
Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387
[TBL] [Abstract][Full Text] [Related]
36. No kinetic interaction between levetiracetam and cyclosporine: a case report.
Franzoni E; Sarajlija J; Garone C; Malaspina E; Marchiani V
J Child Neurol; 2007 Apr; 22(4):440-2. PubMed ID: 17621525
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.
Grosso S; Franzoni E; Coppola G; Iannetti P; Verrotti A; Cordelli DM; Marchiani V; Pascotto A; Spalice A; Acampora B; Morgese G; Balestri P
Seizure; 2005 Jun; 14(4):248-53. PubMed ID: 15911359
[TBL] [Abstract][Full Text] [Related]
38. Retrospective study of the use of levetiracetam in childhood seizure disorders.
Koukkari MW; Guarino EJ
J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience.
Tan MJ; Appleton RE
Seizure; 2004 Apr; 13(3):142-5. PubMed ID: 15010050
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
